Spyre Therapeutics Insider Sold Shares Worth $2,261,831, According to a Recent SEC Filing
MT newswire2026/10/05 07:4603:46 AM EDT, 10/05/2026 (MT Newswires) -- Scott L Burrows, Chief Financial Officer, on September 30, 2026, sold 25,000 shares in Spyre Therapeutics (SYRE) for $2,261,831. Following the Form 4 filing with the SEC, Burrows has control over a total of 79,762 common shares of the company, with 79,762 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000117/xslF345X05/wk-form4_1790990964.xml
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British Pound hits session highs at 1.3420 amid broadbased US Dollar weakness
Cybertruck orders far exceed pre-production capacity, Tesla (TSLA.US) to refund deposits to a large number of customers
Elon Musk stated that Tesla will refund the Cybertruck deposits to a significant number of customers.
Barrick Gold (B.US) Q3 Results Mixed: Benefiting from Gold Price Dividend While Facing Cost Pressures
Barrick Mining (B.US) will release its financial results for the third quarter of 2026 before the U.S. stock market opens on November 9.
Crypto prices
More
